FDA Investigator: Bei Yu
- Bei Yu first started conducting FDA inspections in 2017, with the last inspection in 2019. Over that time, Bei Yu has conducted 6 inspections at 6 companies across 6 sites.
Get Bei Yu's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Intra-Cellular Therapies Inc, New York | 2019
Out-of-stock
Bei Yu
Human Drug Form 483
FDA 483 Merck Sharp & Dohme, Rahway | 2017
Out-of-stock
Bei Yu
Human Drug Form 483
Co-Investigators (13)
- Diane C. Van Leeuwen, FDA Investigator
- Iram R. Hassan, FDA Investigator
- Ni A. Khin, FDA Investigator
- Van Leeuwen, Diane C, FDA Investigator
- Shirley S. Wen, FDA Investigator
- Mathew T. Thomas, FDA Investigator
- Dustin P. Tran, FDA Investigator
- Melanie N. Daniels, FDA Investigator
- David L. Chon, FDA Investigator
- Robin R. Waller, FDA Investigator
- Jean M. Mulinde, FDA Investigator
- Nina Yang, FDA Investigator
- Michael Serrano, FDA Investigator